Publications

Mobility and Clinic Switching Among Postpartum Women Considered Lost to HIV Care in South Africa.

Clouse K, Vermund SH, Maskew M, Lurie MN, MacLeod W, Malete G, Carmona S, Sherman G, Fox MP.

J Acquir Immune Defic Syndr.. 2017 Apr; 74(4):386-389.

Imputing HIV treatment start dates from routine laboratory data in South Africa: a validation study.

Mhairi Maskew, Jacob Bor, Cheryl Hendrickson, William MacLeod,Till Bärnighausen, Deenan Pillay, Ian Sanne, Sergio Carmona, Wendy Stevens, and Matthew P Fox1

BMC Health Serv Res. 2017 Jan; 17(41).

Imputing HIV treatment start dates from routine laboratory data in South Africa: a validation study

Mhairi Maskew, Jacob Bor, Cheryl Hendrickson, William MacLeod, Till Bärnighausen, Deenan Pillay, Ian Sanne, Sergio Carmona, Wendy Stevens and Matthew P Fox

BMC Health Services Research. 2017 Jan; 17(41).

Gender Differences in Mortality and CD4 Count Response Among Virally Suppressed HIV-Positive Patients

Mhairi Maskew, Alana T. Brennan, Daniel Westreich, Lynne McNamara, Patrick MacPhail, and Matthew P. Fox

J Womens Health (Larchmt). 2017 Jan; 22(2):113-120.

Treatment Outcomes and Costs of Providing Antiretroviral Therapy at a Primary Health Clinic versus a Hospital-Based HIV Clinic in South Africa.

Lawrence C. Long , Sydney B. Rosen, Alana Brennan, Faith Moyo, Celeste Sauls, Denise Evans, Shookdev L. Modi, Ian Sanne, Matthew P. Fox

PLOS. 2016 Dec; 11(12).

Changes in second-line regimen durability and continuity of care in relation to national ART guideline changes in South Africa.

Onoya, Brennan A, Berhanu R, van der Berg, Buthelezi, Fox M.

J Int AIDS Soc.. 2016 Dec; 19(1):1-13.

Mortality in the First 3 Months on Antiretroviral Therapy Among HIV-Positive Adults in Low- and Middle-income Countries: A Meta-analysis.

Brennan AT, Long L, Useem J, Garrison L, Fox MP.

J Acquir Immune Defic Syndr.. 2016 Nov;.

A meta-analysis assessing all-cause mortality in HIV-exposed uninfected compared with HIV-unexposed uninfected infants and children

Alana T Brennan, Rachael Bonawitz, Chris J Gill, Donald M Thea, Mary Kleinman, et al.

AIDS. 2016 Sep; 30(15):2351-60.

Impact of choice of NRTI in first-line antiretroviral therapy: a cohort analysis of stavudine vs. tenofovir

Brennan AT, Shearer K, Maskew M, Long L, Sanne I, Fox MP.

Trop Med Int Health. 2014 May; 19(5):490-8.

Poor CD4 recovery and risk of subsequent progression to AIDS or death despite viral suppression in a South African cohort

Simbarashe Takuva, Mhairi Maskew, Alana T Brennan, Lawrence Long, Ian Sanne, and Matthew P Fox

J Int AIDS Society. 2014 Mar; 17(1).

Increases in regimen durability associated with the introduction of tenofovir at a large public-sector clinic in Johannesburg, South Africa

Alana T Brennan, Mhairi Maskew, Prudence Ive, Kate Shearer, Lawrence Long, Ian Sanne and Matthew P Fox

Journal of the International AIDS Society. 2013 Nov; 16(18794).

Strengthening capacity for AIDS vaccine research: analysis of the Pfizer Global Health Fellows Program and the International AIDS Vaccine Initiative

Taryn Vian, Sayaka Koseki, Frank G Feeley, Jennifer Beard

BMC Health Services Research. 2013 Oct; 13(378):1-12.

The Impact of Choice of NNRTI on Short-Term Treatment Outcomes among HIV-Infected Patients Prescribed Tenofovir and Lamivudine in Johannesburg, South Africa

Kate Shearer, Matthew P. Fox, Mhairi Maskew, Rebecca Berhanu, Lawrence Long, Ian Sanne

PLOS ONE. 2013 Aug; 8(8).